Risk factors for lung cancer in patients with scleroderma: A nested case-control study

Annals of the Rheumatic Diseases

Volumn 66, Issue 4, 2007, Pages 551-553

  Pontifex, Eliza K ^a   Hill, Catherine L ^b   Roberts Thomson, Peter ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE;

ADULT; AGED; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LUNG CANCER; LUNG FIBROSIS; MALE; PRIORITY JOURNAL; SCLERODERMA; SMOKING HABIT;

AGE OF ONSET; AGED; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PULMONARY FIBROSIS; SCLERODERMA, LIMITED; SCLERODERMA, SYSTEMIC; SMOKING; SOUTH AUSTRALIA; TIME FACTORS;

EID: 34147208302     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.056424     Document Type: Article

References (14)

1. Pearson JE, Silman AJ. Risk of cancer in patients with scleroderma. Ann Rheum Dis 2003;62:697-9.
2. Hill CL, Nguyen A-M, Roder D, Roberts-Thomson P. Risk of cancer in patients with scleroderma: a population based cohort study. Ann Rheum Dis 2003;62:728-31.
3. Rosenthal AK, McLaughlin JK, Gridley G, Nyren O. Incidence of cancer among patients with systemic sclerosis. Cancer 1995;76:910-914.
4. Chatterjee S, Dombi GW, Severson RK, Mayes MD. Risk of malignancy in scleroderma. A population-based cohort study. Arthritis Rheum 2005;52:2415-24.
5. Daniels CE, Jett JR. Does interstitial lung disease predispose to lung cancer? Curr Opin Pulm Med 2005;11:431-7.
6. Roberts-Thomson PJ, Jones M, Hakendorf P, Kencana Dharmapatni AASS, Walker JG, MacFarlane JG, et al. Scleroderma in South Australia: epidemiological observations of possible pathogenic significance. Intern Med J 2001;31:220-9.
7. Subcommittee for scleroderma criteria of the American Rheumatology Association Diagnostic and Therapeutic Criteric Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1983;23:581-90.
8. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma: classification, subset and pathogenesis. J Rheumatol 1988;25:688-94.
9. Bonett A, Roder D, Milliken L. The South Australian Cancer Registry: a means of assessing cancer incidence, mortality and case survival. Eur J Cancer 1992;28:1923-26.
10. Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000;321:323-9.
11. Abu-Shakra M, Guillemin F, Lee P. Cancer in systemic sclerosis. Arthritis Rheum 1993;36:460-4.
12. Peters-Golden M, Wise RA, Hochberg M, Stevens MB, Wigley FM. Incidence of lung cancer in systemic sclerosis. J Rheumatol 1985;12:1136-9.
13. Roumm AD, Medsger TA Jr. Cancer and systemic sclerosis. Arthritis Rheum 1985;28:1336-40.
14. Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med 2000;161:5-8.